During the past decade, Hospital Naval Marcílio Dias conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Naval Marcílio Dias" #1 sponsor was "Hospital do Coracao" with 2 trials, followed by "Universidade Federal Fluminense" with 2 trials sponsored, "Brazilian Clinical Research Institute" with 1 trials sponsored, "Hospital Israelita Albert Einstein" with 1 trials sponsored and "Saint Luke's Health System" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Naval Marcílio Dias" #1 collaborator was "Hospital Moinhos de Vento" with 3 trials as a collaborator, "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "Hospital Alemão Oswaldo Cruz" with 2 trials as a collaborator, "Hospital Israelita Albert Einstein" with 2 trials as a collaborator and "Hospital Sirio-Libanes" with 2 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Naval Marcílio Dias" are "COVID-19" (1 trials), "Catheter-Associated Urinary Tract Infection" (1 trials), "Central Line-associated Bloodstream Infection (CLABSI)" (1 trials), "Coronavirus Infection" (1 trials) and "Coronavirus Infections" (1 trials). Many other conditions were trialed in "Hospital Naval Marcílio Dias" in a lesser frequency.

Most popular intervention types in "Hospital Naval Marcílio Dias" are "Drug" (4 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "2% chlorhexidine digluconate solution with surface-active agents" (1 trials), "Dapagliflozin 10 milligram (mg)" (1 trials), "Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed" (1 trials), "Group 2: control group with enoxaparin 40mg/d" (1 trials) and "Hydroxychloroquine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Naval Marcílio Dias" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Naval Marcílio Dias". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Naval Marcílio Dias, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Naval Marcílio Dias, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".